We are live on ! Find out more
VNRX icon

VolitionRx

24 hedge funds and large institutions have $8.89M invested in VolitionRx in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.75% less ownership

Funds ownership: 15.54% → 14.79% (-0.75%)

4% less funds holding

Funds holding: 25 → 24 (-1)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

81% less capital inflows, than outflows

Capital inflows: $121K | Capital outflows: $638K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VNRX Hedge Fund Activity: Q2 2018 in Review

24 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in VolitionRx (VNRX) for Q2 2018, worth a combined $8.89M — down 21% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VNRX and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.

The largest buyer was Oppenheimer & Co, opening a new position worth an estimated $82.6K. The largest seller was Skylands Capital, cutting an estimated $202K.

  • 24 institutional investors held VolitionRx (VNRX) as of Q2 2018, down from 25 in Q1 2018.
  • Funds reported $8.89M of VolitionRx stock for Q2 2018, down 21% quarter-over-quarter.
  • 3 funds opened new VolitionRx positions in Q2 2018 and 4 closed out, a net change of -1 holder.
  • The largest VolitionRx buyer in Q2 2018 was Oppenheimer & Co, an estimated $82.6K added.
  • The largest VolitionRx seller in Q2 2018 was Skylands Capital, an estimated $202K sold.

Based on aggregated 13F filings for Q2 2018.